Immunology of tuberculosis: Impact on the development of novel vaccines;Immunologie der tuberkulose: Konsequenzen für die impfstoffentwicklung

Internist

Volumn 44, Issue 11, 2003, Pages 1374-1384

  Ulrichs, T ^a   Kaufmann, S H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

Granuloma; Persistence; T cells; Tuberculosis; Vaccine development

Indexed keywords

ANTIGEN; BCG VACCINE; CD1 ANTIGEN; T LYMPHOCYTE RECEPTOR; T6 ANTIGEN;

CELL FUNCTION; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG DESIGN; GRANULOMA; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INFECTION PREVENTION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; REINFECTION; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME; TUBERCULOSIS;

ANIMALS; COMMUNICABLE DISEASE CONTROL; DRUG DESIGN; GRANULOMA; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 0345305214     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-1057-7     Document Type: Review

References (52)

1. Appelberg R (1994) Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections. Immunobiology 191: 520-525
2. Armstrong JA, Hart PD (1975) Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 142:1-16
3. Riet F, Kremer L, Wolowczuk I, Delacre M, Locht C (2002) Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice. Infect Immun 70: 6549-6557
4. Boring L, Gosling J, Chensue SW et al. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552-2561
5. Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P (2000) ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 68: 791-795
6. Chen P, Ruiz RE, Li Q, Silver RF, Bishai WR (2000) Construction and characterization of a mycobacterium tuberculosis mutant lacking the alternate sigma factor gene, sigF. Infect Immun 68: 5575-5580
7. Chensue SW, Warmington KS, Allenspach EJ et al. (1999) Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol 163: 165-173
8. Cole ST, Brosch R, Parkhill J et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544
9. Ehlers MR, Daffe M (1998) Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol 6: 328-335
10. Emoto M, Emoto Y, Buchwalow IB, Kaufmann SH (1999) Induction of IFN-gamma-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin. Eur J Immunol 29: 650-659
11. Ernst JD (1998) Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 66; 1277-1281
12. Feng Z, Castillo-Chavez C, Capurro AF (2000) A model for tuberculosis with exogenous reinfection. Theor Popul Biol 57: 235-247
13. Flesch IE, Kaufmann SH (1993) Role of cytokines in tuberculosis. Immunobiology 189: 316-339
14. Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93-129
15. Gao JL, Wynn TA, Chang Y et al. (1997) Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185: 1959-1968
16. Gatfield J, Pieters J (2000) Essential role for cholesterol in entry of mycobacteria into macrophages. Science 288: 1647-1650
17. Glickman MS, Cox JS, Jacobs WR (2000) A novel mycolic acid cyclopropane synthetase is required for coding, persistence, and virulence of Mycobocterium tuberculosis. Mol Cell 5: 717-727
18. Heinzel AS, Grotzke JE, Lines RA et al. (2002) HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J Exp Med 196: 1473-1481
19. Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, Kaufmann SH (1998) Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listerio monocytogenes. Proc Natl Acad Sci U S A 95: S299-S304
20. Hogaboam CM, Bone-Larson CL, Lipinski S et al. (1999) Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models. J Immunol 163: 2193-2201
21. Iho S, Yamamoto T, Takahashi T, Yamamoto S (1999) Oligodeoxynucleotides containing palindrome sequences with internal 5′-CpG-3′ act directly on human NK and activated T cells to induce IFN-gamma production in vitro. J Immunotro 163: 3642-3652
22. Kaufmann SH (1996) Gamma/delta and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci U S A 93: 2272-2279
23. Kaufmann SH (2000) Is the development of a new tuberculosis vaccine possible? Nat Med 6: 955-960
24. Kaufmann SH (2001) How can immunology contribute to the control of tuberculosis? Nature Rev Immunol 1: 20-30
25. Kaufmann SH, Schaible UE (2003) A dangerous liaison between two major killers: Mycobacterium tuberculosis and HIV target dendritic cells through DC-SIGN. J Exp Med 197: 1-5
26. Keane J, Gershon S, Wise RP et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098-1104
27. Le Cabec V, Cols C, Maridonneau-Parini I(2000) Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect Immun 68: 4736-4745
28. Losana G, Rigamonti L, Borghi I et al. (2002) Requirement for both IL-12 and IFN-gamma signaling pathways in optimal IFN-gamma production by human T cells. Eur J Immunol 32:693-700
29. MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350
30. Maini R, St Clair EW, Breedveld F (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354: 1932-1939
31. Means TK, Lien E, Yoshimura A, Wang S, Golenbock DT, Fenton MJ (1999) The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 163: 6748-6755
32. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ (1999) Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163: 3920-3927
33. Morita CT, Mariuzza RA, Brenner MB (2000) Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol 22: 191-217
34. Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S (1991) Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 59: 3021-3025
35. Porcelli SA, Modlin RL (1999) The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 17:297-329
36. Romeyn JA (1970) Exogenous reinfection in tuberculosis. Am Rev Respir Dis 101: 923-927
37. Scança CA, Mohan VP, Yu K et al. (2000) Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of Interferon gamma and nitric oxide synthase 2. J Exp Med 192: 347-358
38. Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, Hagens K, Modlin RL, Brinkmann V, Kaufmann SH (2003) Apoptosis facilitates antigen presentation to T lymphocytes through MHC-1 and CD1 in tuberculosis. Nat Med 9: 1039-1046
39. Shen Y, Zhou D, Qiu L et al. (2002) Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 295: 2255-2258
40. Shiloh MU, Nathan CF (2000) Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Curr Opin Microbiol 3: 35-42
41. Stead WW (1967) Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis 95: 729-745
42. Stenger S, Mazzaccaro RJ, Uyemura K et al. (1997) Differential effects of cytolytic T cell subsets on intracellular infection. Science 276: 1684-1687
43. Stenger S, Niazi KR, Modlin RL (1998) Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol 161: 3582-3588
44. Tailleux L, Schwartz O, Herrman JL et al. (2003) DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197: 121-127
45. Takeshita F, Leifer CA, Gursel I et al. (2001) Cutting edge: Role of Toll-like receptor 9 in CpG DNA-Induced activation of human cells. J Immunol 167: 3555-3558
46. Ulrichs T, Kaufmann SH (2002) Mycobacterial persistence and immunity. Front Biosci 7: D458-D469
47. Ulrichs T, Porcelli S. (2000) CD1 proteins: targets of T cell recognition in innate and adaptive immunity. Rev Immunogenet 2:416-432
48. van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P (2000) Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 30:3689-3698
49. van Rie A, Warren R, Richardson M et al. (1999) Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 341: 1174-1179
50. Warmington KS, Boring L, Ruth JH et al. (1999) Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. Am J Pathol 154: 1407-1416
51. WHO (2003)http://www.who.int/gtb
52. Young S, O'Donnell M, Lockhart E et al. (2002) Manipulation of immune responses to Myobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin. Immunol Cell Biol 80: 209-215